Get started
Work

Renal Artery Stent Outcomes

Year: 2015
Type: article
DOI: 10.1016/j.jacc.2015.09.073
Authors: Timothy P. Murphy, Christopher J. Cooper, Alan H. Matsumoto, Donald E. Cutlip, Karol M. Pencina, Kenneth Jamerson, Katherine R. Tuttle, Joseph I. Shapiro, Ralph D’Agostino, Joseph Massaro, William Henrich, Lance D. Dworkin
Institutions: Brown University, Rhode Island Hospital, Lifespan, University of Toledo, University of Virginia, Beth Israel Deaconess Medical Center, Harvard University, Baim Institute for Clinical Research, University of Michigan, Providence Sacred Heart Medical Center, University of Washington, Marshall University, Boston University, The University of Texas at San Antonio Health Science Center
Language: English
Field: Medicine
Open Access status: bronze
Funders: Pfizer, AstraZeneca, Boston Scientific Corporation, National Institutes of Health, National Heart, Lung, and Blood Institute, Cordis
Awards: G1225339941, CORAL Angiographic Core Laboratory, G2241494445, Receptor Na/K-ATPase Antagonists As Novel Therapeutics For Renal/Cardiac Diseases, G3681846331, Coral: Central GFR and Biochemistry Laboratory, CORAL: Economics and QOL Core Laboratory, G9000287629, G9000334438
OpenAlex ID: W2186104171
FWCI: 6.322
Cites: 15
Cited by: 46
Related to: 10